231 related articles for article (PubMed ID: 9865514)
1. Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats.
Dachicourt N; Bailbé D; Gangnerau MN; Serradas P; Ravel D; Portha B
Eur J Pharmacol; 1998 Nov; 361(2-3):243-51. PubMed ID: 9865514
[TBL] [Abstract][Full Text] [Related]
2. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
Serradas P; Bailbé D; Portha B
Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
[TBL] [Abstract][Full Text] [Related]
3. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
Portha B; Serradas P
Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
[TBL] [Abstract][Full Text] [Related]
4.
Zambrana S; Lundqvist LCE; Mamani O; Catrina SB; Gonzales E; Östenson CG
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037028
[No Abstract] [Full Text] [Related]
5. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
[TBL] [Abstract][Full Text] [Related]
6. Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes.
Portha B; Serradas P; Bailbé D; Suzuki K; Goto Y; Giroix MH
Diabetes; 1991 Apr; 40(4):486-91. PubMed ID: 2010050
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.
Wajchenberg BL; Santomauro AT; Giannella-Neto D; Borghi VC; Porrelli RN
Diabetes Res Clin Pract; 1992 Aug; 17(2):89-97. PubMed ID: 1425152
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protein-tyrosine phosphatases stimulates insulin secretion in pancreatic islets of diabetic Goto-Kakizaki rats.
Chen J; Ostenson CG
Pancreas; 2005 May; 30(4):314-7. PubMed ID: 15841039
[TBL] [Abstract][Full Text] [Related]
9. Preserved initiatory and potentiatory effect of alpha-ketoisocaproate on insulin release in islets of glucose intolerant rats.
Guenifi A; Abdel-Halim SM; Efendic S; Ostenson CG
Diabetologia; 1998 Nov; 41(11):1368-73. PubMed ID: 9833946
[TBL] [Abstract][Full Text] [Related]
10. Gliclazide at a lower concentration than therapeutic dose increases the sensitivity of insulin secretion to glucose in perfused rat pancreas.
Mokuda O; Tanaka H; Hayashi T; Ooka H; Okazaki R
Diabetes Metab; 2004 Apr; 30(2):193-6. PubMed ID: 15223993
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of pancreatic beta-cell secretion in Type 2 diabetic patients treated with gliclazide and glibenclamide.
van der Wal PS; Heine RJ
Diabetes Res Clin Pract; 2001 May; 52(2):103-11. PubMed ID: 11311964
[TBL] [Abstract][Full Text] [Related]
12. Release of amylin from perfused rat pancreas in response to glucose, arginine, beta-hydroxybutyrate, and gliclazide.
Inoue K; Hisatomi A; Umeda F; Nawata H
Diabetes; 1991 Aug; 40(8):1005-9. PubMed ID: 1860552
[TBL] [Abstract][Full Text] [Related]
13. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.
Tourrel C; Bailbe D; Lacorne M; Meile MJ; Kergoat M; Portha B
Diabetes; 2002 May; 51(5):1443-52. PubMed ID: 11978641
[TBL] [Abstract][Full Text] [Related]
14. Beta-cell growth in the neonatal Goto-Kakisaki rat and regeneration after treatment with streptozotocin at birth.
Movassat J; Portha B
Diabetologia; 1999 Sep; 42(9):1098-106. PubMed ID: 10447522
[TBL] [Abstract][Full Text] [Related]
15. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
Gregorio F; Ambrosi F; Cristallini S; Pedetti M; Filipponi P; Santeusanio F
Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021
[TBL] [Abstract][Full Text] [Related]
16. Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes.
Fierabracci V; De Tata V; Pocai A; Novelli M; Barberà A; Masiello P
Endocrine; 2002 Nov; 19(2):177-84. PubMed ID: 12588048
[TBL] [Abstract][Full Text] [Related]
17. Impaired insulin secretion and excessive hepatic glucose production are both early events in the diabetic GK rat.
Picarel-Blanchot F; Berthelier C; Bailbé D; Portha B
Am J Physiol; 1996 Oct; 271(4 Pt 1):E755-62. PubMed ID: 8897865
[TBL] [Abstract][Full Text] [Related]
18. Effect of 6-month gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial continuous subcutaneous insulin infusion-induced normoglycemia.
Della Casa L; del Rio G; Glaser B; Cerasi E
Am J Med; 1991 Jun; 90(6A):37S-45S. PubMed ID: 1872303
[TBL] [Abstract][Full Text] [Related]
19. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.
Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A
Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664
[TBL] [Abstract][Full Text] [Related]
20. Effect of high dietary fat on insulin secretion in genetically diabetic Goto-Kakizaki rats.
Shang W; Yasuda K; Takahashi A; Hamasaki A; Takehiro M; Nabe K; Zhou H; Naito R; Fujiwara H; Shimono D; Ueno H; Ikeda H; Toyoda K; Yamada Y; Kurose T
Pancreas; 2002 Nov; 25(4):393-9. PubMed ID: 12409835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
